DE3684882D1 - Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels. - Google Patents

Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.

Info

Publication number
DE3684882D1
DE3684882D1 DE8686850396T DE3684882T DE3684882D1 DE 3684882 D1 DE3684882 D1 DE 3684882D1 DE 8686850396 T DE8686850396 T DE 8686850396T DE 3684882 T DE3684882 T DE 3684882T DE 3684882 D1 DE3684882 D1 DE 3684882D1
Authority
DE
Germany
Prior art keywords
composition
mmol
cell metabolism
conditions
overweight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686850396T
Other languages
English (en)
Inventor
Nels Henningsen
Steen Jaedig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDINA HB
PREVENT FA
Original Assignee
MEDINA HB
PREVENT FA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDINA HB, PREVENT FA filed Critical MEDINA HB
Application granted granted Critical
Publication of DE3684882D1 publication Critical patent/DE3684882D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Special Wing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
DE8686850396T 1985-11-22 1986-11-18 Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels. Expired - Fee Related DE3684882D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505527A SE468074B (sv) 1985-11-22 1985-11-22 Preparat foer foerbaettring av den cellulaera metabolismen

Publications (1)

Publication Number Publication Date
DE3684882D1 true DE3684882D1 (de) 1992-05-21

Family

ID=20362216

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8686850396T Expired - Fee Related DE3684882D1 (de) 1985-11-22 1986-11-18 Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.
DE198686850396T Pending DE223762T1 (de) 1985-11-22 1986-11-18 Zusammensetzung fuer den zellstoffwechsel.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE198686850396T Pending DE223762T1 (de) 1985-11-22 1986-11-18 Zusammensetzung fuer den zellstoffwechsel.

Country Status (10)

Country Link
EP (1) EP0223762B1 (de)
JP (1) JPH07100660B2 (de)
AT (1) ATE74760T1 (de)
AU (1) AU592385B2 (de)
CA (1) CA1275927C (de)
DE (2) DE3684882D1 (de)
DK (1) DK164200C (de)
FI (1) FI864749A (de)
NO (1) NO175845C (de)
SE (1) SE468074B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207800B (en) * 1990-05-10 1993-06-28 Andras Sikter Process for producing composition for improving condition and for treating different illnesses
US5639471A (en) * 1995-06-06 1997-06-17 Campbell Soup Company Method for determining diet program effectiveness
DE19925483A1 (de) * 1998-06-04 2000-02-03 Ludwig Schwebel Wirkstoff zur Behandlung der Zuckerkrankheit
GB9819530D0 (en) 1998-09-09 1998-10-28 Smithkline Beecham Plc Novel compositions and use
US9585827B2 (en) * 2000-01-21 2017-03-07 The Procter & Gamble Company Kits comprising a beverage composition and information for use
CN102949413B (zh) * 2012-06-08 2014-12-03 辽宁海思科制药有限公司 一种转化糖电解质注射液的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1796976A (en) * 1975-09-23 1978-04-06 Johnson & Johnson Electrolyte mixtures and drinks
US4322407A (en) * 1978-12-11 1982-03-30 Vitapharm Pharmaceutical Pty. Ltd. Electrolyte drink

Also Published As

Publication number Publication date
SE8505527L (sv) 1987-05-23
AU6513386A (en) 1987-05-28
FI864749A0 (fi) 1986-11-21
SE8505527D0 (sv) 1985-11-22
CA1275927C (en) 1990-11-06
NO864682L (no) 1987-05-25
FI864749A (fi) 1987-05-23
DK560286A (da) 1987-05-23
NO175845B (de) 1994-09-12
SE468074B (sv) 1992-11-02
EP0223762B1 (de) 1992-04-15
EP0223762A1 (de) 1987-05-27
AU592385B2 (en) 1990-01-11
NO864682D0 (no) 1986-11-21
JPH07100660B2 (ja) 1995-11-01
NO175845C (no) 1994-12-21
ATE74760T1 (de) 1992-05-15
DK164200B (da) 1992-05-25
DK560286D0 (da) 1986-11-21
JPS62171654A (ja) 1987-07-28
DK164200C (da) 1992-10-19
DE223762T1 (de) 1987-10-15

Similar Documents

Publication Publication Date Title
Bleiler et al. Creatinine excretion: variability and relationships to diet and body size
Sharief et al. Differences in dietary-induced thermogenesis with various carbohydrates in normal and overweight men
Yu et al. Nutritional influences on aging of Fischer 344 rats: I. Physical, metabolic, and longevity characteristics
Van Itallie et al. Ketogenesis and hyperketonemia
Boothby et al. Basal metabolism
Elwyn et al. Influence of increasing carbohydrate intake on glucose kinetics in injured patients.
Dowdy et al. Copper-molybdenum interaction in sheep and chicks
DE3856435D1 (de) Verwendung von Gallsäure-aktiviertem Lipase als Diätsupplement
DE3684882D1 (de) Verwendung einer zusammensetzung zur herstellung eines medikaments zur verbesserung des zellstoffwechsels.
NO180544C (no) Fremgangsmåte for fremstilling av humant IL-3 (Pro-8), ekspresjonsvektor, vektor og transformert levende vertscelle
Briscoe et al. Diurnal variations in calcium and magnesium excretion in man
Cruickshank et al. A study of available substrates for the endogenous respiration of skin “in vitro.”
DE3685584D1 (de) Vorrichtung zur kontinuierlichen oder diskontinuierlichen verabreichung von insulin in den menschlichen koerper.
Elkin et al. Modification of caloric intake in anorexia nervosa: An experimental analysis
Campbell et al. Effect of severe muscular work on composition of the urine
Chen et al. Zinc attenuation of GDP binding to brown adipocytes mitochondria in genetically obese (ob/ob) mice
Miller Overfeeding in man
Percival et al. Interaction between methionine, fat and choline in the young rat
Robin et al. Metabolic patterns during physiologic sleep: i. blood glucose regulation during sleep in normal and diabetic subjects
White et al. Fluid replacement needs of well-trained male and female athletes during indoor and outdoor steady state running
Milman Internal and external motivation for learning
Dann The Question of Carbohydrate Production from Fat with Special Reference to Diabetes
Thompson Thiamine and the metabolism of pyruvate
KOZYREVSKAIA et al. The effects of different levels of motor activity on sweat electrolyte composition
WD Physiological Chemistry.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee